Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aadi Bioscience
Aadi Bioscience
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fyarro
Sirolimus
2021-11-22
2029-2040
Kidney transplantation
,
Perivascular epithelioid cell neoplasms
,
Graft rejection
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sirolimus
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
non-small-cell lung carcinoma
,
epilepsy
,
drug resistant epilepsy
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasms
,
recurrence
,
perivascular epithelioid cell neoplasms
,
neuroendocrine tumors
,
glioblastoma
,
glioma
,
colorectal neoplasms
,
syndrome
,
leigh disease
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
neoplasm metastasis
,
lung neoplasms
,
carcinoma
,
endometrial neoplasms
,
endometrioid carcinoma
,
pancreatic neoplasms
,
stomach neoplasms
,
intestinal neoplasms
,
islet cell adenoma
Marizomib
recurrence
,
glioblastoma
,
glioma
Calcium dobesilate
cataract
,
keratitis
,
blepharitis
,
conjunctivitis
,
allergic conjunctivitis
,
sjogren's syndrome
,
dry eye syndromes
,
eye diseases
Bevifimod
neoplasms
,
healthy volunteers/patients
,
non-small-cell lung carcinoma
Antineoplaston a10
autism spectrum disorder
,
uterine cervical neoplasms
,
rheumatoid arthritis
,
arthritis
,
breast neoplasms
,
covid-19
,
pneumonia
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
depression
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use